Adrenal gland- UPK1B negative adrenocortical adenoma.

Breast- UPK1B negative invasive breast cancer of no special type (NST).

Colon- UPK1B negative colorectal adenocarcinoma.

Esophagus- Adenocarcinoma showing a moderate to strong UPK1B immunostaining of tumor cells.

Esophagus- Squamous cell carcinoma showing a strong UPK1B positivity in most tumor cells.

Kidney- Papillary renal cell carcinoma with moderate to strong UPK1B immunostaining of tumor cells.

Kidney- UPK1B negative clear cell renal cell carcinoma.

Lung- Malignant mesothelioma (epitheloid) with strong UPK1B immunostaining of all tumor cells.

Lung- Squamous cell carcinoma with strong UPK1B positivity in the majority of tumor cells.

Lung- Strong UPK1B immunostaining of all tumor cells in an epitheloid malignant mesothelioma.

Lung- UPK1B negative adenocarcinoma.

Lung- UPK1B negative small cell carcinoma.

Ovary- Endometroid carcinoma with strong UPK1B immunostaining of tumor cells.

Ovary- Serous high-grade carcinoma with a moderate to strong UPK1B immunostaining of the majority of tumor cells.

Pancreas- UPK1B negative neuroendocrine tumor.

Penis- UPK1B negative squamous cell carcinoma.

Prostate- UPK1B negative adenocarcinoma (Gleason 3+3=6).

Salivary gland- Warthin tumor with strong UPK1B immunostaining of a fraction of tumor cells.

Skin- UPK1B negative basal cell carcinoma.

Skin- UPK1B negative squamous cell carcinoma.

Soft tissue- UPK1B negative liposarcoma.

Stomach- UPK1B negative gastric adenocarcinoma.

Stomach- UPK1B negative gastrointestinal stromal tumor (GIST).

Testis- UPK1B negative seminoma.

Testis- UPK1B negative yolk sack tumor.

Thyroid- UPK1B negative papillary carcinoma.

Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong UPK1B immunostaining of tumor cells.

Urinary bladder- UPK1B negative sarcomatoid urothelial carcinoma.